Research and Development

France has re-branded its leading biotech cluster the ‘Alsace Biovalley’ to help the region compete for investment in Europe and …

Access licenses MuGard to Rhei Pharmaceuticals Access Pharmaceuticals and Rhei Pharmaceuticals have signed a definitive licensing agreement under which Rhei …

Swiss pharmaceutical company Roche is to invest $390 million (430 million Swiss francs) in three of its European sites to …

 A look back at some of the biggest stories to affect the UK pharmaceutical industry in 2007, including a string …

AstraZeneca's Crestor will go head-to-head with Pfizer's mega-brand Lipitor in a global trial assessing the two statins in cardiovascular disease. …

Pfizer will partner with German biopharmaceutical company Scil Technology to develop and commercialise a new early-stage biotech treatment for cartilage …

Cancer Research UK is investing ten million pounds in drug discovery projects at four UK universities. Project leaders at Imperial …

Competitive obtains license rights for breast cancer testCompetitive Technologies has signed a license and commercialization agreement for rights to the …

The pharmaceutical industry has made a major reduction in the number of rodents used in pre-clinical drug testing after an …

John Patterson is an AstraZeneca man through-and-through, having spent nearly all his working life at the company. But over the …

GlaxoSmithKline's cervical cancer vaccine Cervarix has suffered a setback in the US, where regulators have refused to approve it until …

BioMS's multiple sclerosis trial receives positive review from DSMBThe Data Safety Monitoring Board has reviewed data from BioMS Medical's ongoing …

Japanese pharma company Eisai has acquired Minnesota-based biotech MGI Pharma for $3.9 billion, significantly boosting its oncology business.It is Eisai’s …

GSK has secured two new early-stage biotech licensing deals to boost its product pipeline.The UK-based group unveiled one partnership with …